Silver Book Fact

Each flu case prevented could save $60 to $4,000

The influenza vaccination could save between $60 and $4,000 per case prevented.

Pearson, Michael L., Carolyn B. Bridges, and Scott A. Harper. Influenza Vaccination of Health-Care Personnel. Morbidity and Mortality Weekly Report. February 24, 2006; 55(RR02): 1-16. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5502a1.htm

Reference

Title
Influenza Vaccination of Health-Care Personnel
Publication
Morbidity and Mortality Weekly Report
Publication Date
February 24, 2006
Authors
Pearson, Michael L., Carolyn B. Bridges, and Scott A. Harper
Volume & Issue
Volume 55, Issue RR02
Pages
1-16
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value
  • Future Value

Related Facts

  • Potential value of pneumonia vaccine
    Use of PCV13 (13-valent pneumococcal conjugate vaccine) in older adults is estimated to have the potential to reduce total healthcare costs by $3.5 billion and total societal costs by $7.4…  
  • Cost of pneumonia vaccine
    Addition of PCV13 (13-valent pneumococcal conjugate vaccine) to previously recommended pneumococcal polysaccharide vaccine for immunocompromised adults cost $70,937 per quality adjusted life year compared to no vaccine.  
  • Significant savings from zoster vaccine
    In a cost-effectiveness analysis, investigators estimated the zoster vaccine cost $44,000 per quality-adjusted life year saved for a 70-year-old woman.  
  • Over 6 years, flu vaccine prevented ~13 million cases
    Over a 6-year period (2005 – 2011), the influenza vaccine prevented an estimated 13 million influenza cases–between 1.1 million and 5 million annually.  
  • Use of pneumonia vaccine in children reduced rates in adults age 65+
    Within a year of introduction of PCV7 (7-valent pneumococcal conjugate vaccine) for use in the U.S. in infants, children under 2 years, and high risk children ages 2 to 4;…